Biotech

Biotechnology, gene editing, biopharma platforms, and clinical pipelines.

  • 9 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Biotech

ANTIKOR portal
antikor.info > en > articles > 862687-osobnjak_za_300_tysjach_dollarov_i_laboratorija_dlja_svoih_gosleksluhbu_likvidirovali_i_sozdali_novyj_organ

A $300,000 mansion and a lab for???their own???: State Medicines Service liquidated and new agency created

4+ hour, 51+ min ago   (458+ words) A $300,000 mansion and a lab for “their own”: State Medicines Service liquidated and new agency created АНТИКОР - A $300,000 mansion and a lab for?their own?: State Medicines Service liquidated and new agency created This is reported by Glavcom. The previous…...

TheStreet Pro
pro.thestreet.com > trade-ideas > how-to-trade-this-2-billion-biotech-name-moving-quickly-toward-profit

How to Trade This $2 Billion Biotech Name Moving Quickly Toward Profit

1+ hour, 31+ min ago   (424+ words) Here’s our covered-call idea. The first full trading week of September was an eventful one. There was the 25th anniversary of the 9/11 attacks on Friday. Hostilities also escalated notably across the Middle East. This pushed oil up sharply with Brent and…...

Google News
kashmirlife.net > skuast-k-scholar-wins-national-bio-entrepreneurship-competition-451585

SKUAST-K Scholar Wins National Bio-Entrepreneurship Competition | Kashmir Life - Latest News & Breaking News from Kashmir

2+ hour, 29+ min ago   (224+ words) SRINAGAR: Bushra Naaz, a PhD scholar at Sher-e-Kashmir University of Agricultural Sciences and Technology-Kashmir (SKUAST-K), has won the National Bio Entrepreneurship Competition (NBEC) 2026 held in Bengaluru, bringing national recognition to the university. Naaz, who is pursuing her research under the…...

KELO-AM
kelo.com > 09/11/2026 > novartis-investors-turn-spotlight-on-ma-after-trial-setbacks

Novartis investors turn spotlight on M&A after trial setbacks

2+ day, 11+ hour ago   (759+ words) By Bhanvi Satija, Oliver Hirt and Marleen Kaesebier LONDON/ZURICH, Sept 11 (Reuters) – Novartis investors are set to step up scrutiny of the Swiss group’s dealmaking strategy after setbacks to drugs it acquired through mergers and acquisitions hit its shares, raising…...

Raleigh News & Observer
newsobserver.com > news > business > article317221481.html

Novartis expands in Wake. Morrisville doubles incentive, lowers two requirements

5+ hour, 31+ min ago   (637+ words) Morrisville sweetened its deal with Novartis as the Swiss drugmaker expanded its investment in town. It also lowered two of the requirements the company must meet to qualify for the nearly doubled incentive. Novartis does not get the town’s estimated…...

The New Times
newtimes.co.rw > article > 38921 > news > rwanda > six-startups-share-rwf60m-in-imbuto-backed-funding

Six startups share Rwf60m in Imbuto-backed funding

1+ hour, 33+ min ago   (507+ words) | The New Times The New Times...

@kalkineca
kalkinemedia.com > ca > stocks > healthcare > sernova-biotherapeutics-in-focus-across-canadas-biotechnology-s

Sernova Biotherapeutics in Focus Across Canada’s Biotechnology S

13+ hour, 15+ min ago   (44+ words) Kalkine Media Transat A.T. (TSX:TRZ): Why Analysts Keep Cutting Targets? What's Really Driving WSP Global's (TSX:WSP) Latest Narrative? George Weston: Operations and TSX Sector Context Premium Brands Holdings in Focus Across Canada’s Food Processing...

Knowridge Science Report
knowridge.com > 2026 > 09 > tiny-catalyst-could-turn-plant-waste-into-valuable-chemicals

Tiny Catalyst Could Turn Plant Waste Into Valuable Chemicals

5+ hour, 47+ min ago   (496+ words) ...

MarketScreener
marketscreener.com > news > 133-900-preferred-stock-of-bridgebio-pharma-inc-are-subject-to-a-lock-up-agreement-ending-on-13-se-ce785bdcd98bf621

133,900 Preferred Stock of BridgeBio Pharma, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2026.

15+ hour, 54+ min ago   (144+ words) marketscreener.com 133,900 Preferred Stock of BridgeBio Pharma, Inc are subject to a Lock-Up Agreement Ending on 13-SEP-2026 These Preferred Stock will be under lockup for 31 days starting from 13-AUG-2026 to 13-SEP-2026.Details:The selling stockholder has agreed with the underwriters,…...

Jamaica Observer
jamaicaobserver.com > 09/13/2026 > european-tech-entrepreneur-launch-psychedelic-venture-jamaica

European tech entrepreneur to launch psychedelic venture in Jamaica

10+ hour, 46+ min ago   (1236+ words) EUROPEAN technology entrepreneur and inventor Brayden Olson is betting big on Jamaica. The Spiritus Inc founder believes the island has major potential to benefit from the globally expanding psychedelic marketplace. To this end, Olson’s company — which developed and currently markets…...